Elementor Newsfeed

All
Regulatory
Non regulatory

Elementor Reports

Elementor Shares

Graph

Elementor Post grid

25 June, 2024

CLS Newsletter, June 2024

Now, when summer is approaching and we're all looking forward to enjoying some days off, it's time to sumarize the news from the first half of 2024.

Read more
26 April, 2024

CLS at Imperial Prostate Masterclass in London

The Imperial Prostate Masterclass meeting in London brings together key opinion leaders in urology and experts in focal therapy from around the world. AS part of the program CLS hosted a hands-on training session.

Read more
31 January, 2024

CLS Newsletter, January 2024

For CLS it has been an intense start to the year with many positive news. Read about what has been happening with a focus on actions to future proof our core technology, an update on market expansion, andew company presentations.

Read more
20 December, 2023

CLS at Focal Therapy Masterclass meeting in Paris

For CLS this meeting offered a perfect opportunity to meet with both the leading experts, and with clinicians about to introducing focal therapy in their clinic.

Read more
17 November, 2023

Customer Experience AVANT Concierge Urology

Learn about our progress within the Mobile Service Provider Model enabling more clinics to treat prostate cancer patients.

Read more
7 November, 2023

Podcast Episode with Insight from the US Market

Listen to a podcast episode with Michael Magnani, President of CLS Americas and Dr Garrett D. Pohlman, urologist at Kearney and the host of the Prostate Health Podcast. They had an engaging discussion around the key features and benefits of using the TRANBERG system for the treatment of low to intermediate localized prostate cancer.

Read more
1 November, 2023

CLS Supports Movember

This month, men all around the world are growing mustaches to raise awareness for men's health issues, such as prostate cancer, testicular cancer, mental health, and suicide prevention. It's more than just a mustache; it's a movement to make a difference in the lives of men everywhere.

Read more
22 September, 2023

Newsletter September 2023 with Commercial & Medical Milestones

In this edition of our newsletter, you can read more about CLS’s commercial and medical milestone that was achieved at AVANT Concierge Urology in the US, and exhibitions where our TRANBERG® system and the ClearPoint Prism™ system, powered by CLS, have been demonstrated. We are also proud to present three new members that will strengthen the CLS team.

Read more
6 September, 2023

Interview with CLS's Executive VP Operations – Jimmy Johansson

With his long experience from the medical device and healthcare sectors, Jimmy Johansson has been a great asset to CLS since 2015. Among other things, Jimmy was the project manager behind the development of Thermoguide™ Workstation, our tool for monitoring and control of MRI-guided laser ablation. In May this year Jimmy was appointed CLS´s Executive VP Operations. This is a new coordinating management function created to streamline our operations and secure the company’s continued growth. We caught up with Jimmy to hear more. Joel has shared his journey with CLS. Let’s hear what he said.

Read more
29 August, 2023

NEW: Video showing how laser ablation is monitored using CLS Thermoguide™ Workstation

Watch our new video from a patient case to get an insight into how physicians can monitor a laser ablation procedure in near real time.

Read more
1 August, 2023

Interview with CLS's Director of Clinical Operations - Joel Hix

We are happy to introduce Joel Hix, Director of Clinical Operations at CLS Americas. Joel has over 15 years of senior management experience in operations, sales, marketing, and service with leading medical device manufacturers including Boston Scientific and Healthtronics.

Read more
28 June, 2023

Abstract from the SUS Study to be presented during the ESSFN Congress in Stockholm in September

For the first time results from the CLS-sponsored study at Skåne University Hospital (SUS) will be presented and discussed during an international scientific congress. We are happy to share the abstract OP033 “Laser interstitial thermal therapy using an uncooled laser catheter in a diagnostic MR suite” by Dr Hjalmar Bjartmarz et al.

Read more
5 May, 2023

CLS Americas and Unio Health Partners Announce Clinical Study

We are happy to share that CLS Americas has entered into an agreement with Genesis Research, LLC, an affiliate of Unio Health Partners, to conduct a Phase I clinical study titled, “Micro Ultra-Sound Guided, Transperineal Focal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

Read more
13 April, 2023

CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center

Under the agreement, NIHCC will access the clinical utility of the CLS’s TRANBERG® Thermal Therapy System towards MRI/Ultrasound fusion-guided focal laser ablation (FLA) of prostate tissue and prostate cancer in male patients.

Read more
21 March, 2023

NEW: Animation showing Fusion-guided Focal Laser Ablation in Prostate Cancer

We are proud to release a detailed video animation of the minimally invasive, fusion-guided, focal laser ablation (FLA) of a prostate tumor using the TRANBERG™ Thermal Therapy System.

Read more
21 March, 2023

Post-Market Study to Evaluate CLS’s TRANBERG Thermal Therapy System by HALO Dx

We are happy to share that HALO Diagnostics, Inc. (HALO Dx) will evaluate the safety and short term efficacy of CLS’s TRANBERG® Thermal Therapy System for treating low-to-medium risk prostate cancer patients.

Read more
1 February, 2023

How it Works – Learn more about Laser Ablation in Neurosurgery

Since CLS´s laser ablation system for neurosurgery was cleared by the FDA in September last year development has progressed rapidly. But how does it actually work? We explain in this news post.

Read more
19 January, 2023

Press Release from Skåne University Hospital on the Ongoing Study using CLS Products for Neurosurgery inside the MRI Camera

Today Skåne University Hospital (SUS) published a press release with the title “Laser surgery in a magnetic camera – new help for patients with brain tumors”. The PM provides an insight to the ongoing study using CLS products for laser surgery inside a MRI camera. The hospital writes that doctors now can treat patients with hard-to-reach brain tumors that medical care was previously unable to help. So far two patients with brain tumors have been successfully treated as part of the study.

Read more
15 December, 2022

Interview with and research by Dr Eric Walser University of Texas Medical Branch

Dr Eric Walser is an internationally recognized interventional radiologist with extensive clinical experience of using non-surgical ablation for the treatment of small tumors as an alternative to traditional surgery. Dr Eric Walser uses the TRANBERG® Thermal Therapy System to treat localized prostate cancer in clinical practice.

Read more
12 December, 2022

CLS announces first glioblastoma patient treated with the MR-guided Laser Interstitial Thermal Therapy (MRg LITT) in the study at Skåne University Hospital

CLS today announced that the first patient has been safely treated in the clinical trial at Skåne University Hospital (SUS) aiming to evaluate MR-guided Laser Interstitial Thermal Therapy (MRg LITT) for glioblastoma ablation.

Read more
28 November, 2022

Clinical data from a Phase II trial using CLS TRANBERG products presented during RSNA 2022 Annual Meeting

The RSNA (Radiological Society of North America) annual meeting is ongoing in Chicago, the US. Yesterday, interim data from the ongoing study in Toronto using CLS´s TRANBERG products, was presented by the principal investigator MD Sangeet Ghai.   

Read more
24 November, 2022

Our CTO Cristina Pantaleone awarded Technician of the Year by the Chamber of Commerce

We are happy to announce that our Chief Technology Officer Cristina Pantaleone today has been awarded Technician of the Year by the Chamber of Commerce and Industry of Southern Sweden.

Read more
8 November, 2022

Scientific presentations related to the use of CLS TRANBERG® products at the 13th iMRI Symposium in Leipzig

We want to highlight a couple of scientific presentations held during the 13th Interventional MRI Symposium 2022 in Leipzig, October 14-15, 2022. This event provides an ideal platform for researchers, clinicians, and healthcare professionals alike to present their latest results within interventional MRI.

Read more
2 November, 2022

Interview with our CTO and VP Clinical Affairs – How CLS contributes to better treatment of Prostate Cancer

Our CTO Cristina Pantaleone and VP Medical Affairs Hoda Tawfik, explain how the TRANBERG® Thermal Therapy Systems have been designed for precise and safe focal therapy of soft tissue, such as the prostate gland, and what kind of research CLS is now supporting.

Read more
1 November, 2022

CLS Supports Movember - Introduction by CEO Dan J. Mogren

CEO Dan J. Mogren introduces our support for Movember. This annual campaign is all about raising awareness around male health, and specifically around prostate cancer. It is one of the most common cancer forms among men, but more can be done to spread knowledge about the disease.

Read more
17 October, 2022

Demonstration of Targeted Focal Therapy with Fusion-guided Laser Ablation by Dr. Fernando J. Bianco

Combined products enable minimally-invasive, high precision laser focal therapy of prostate tumors in an office or clinic. CLS Americas and Focalyx Technologies, today announced the companies will exhibit and demonstrate their respective products.

Read more
26 September, 2022

CLS receives FDA 510(k) clearance for our MR guided laser ablation system in neurosurgery

We are proud to announce that CLS has received FDA 510(k) clearance for our MR guided laser ablation system in neurosurgery!

Read more
15 September, 2022

Skåne University Hospital prepares to operate patients inside the MRI Scanner

The first patient will shortly be treated with the CLS laser ablation system in a sponsored study at Skåne University Hospital. The Swedish medical journal Läkartidningen now reports from the hospital.

Read more
7 September, 2022

Imperial Prostate Masterclass meeting in London, UK, September 9-10

We are now in the final preparations for the Imperial Prostate Masterclass meeting in London taking place this week. This is a small meeting, but this is also where we well meet the leading specialists and KOLs in the field.

Read more
24 August, 2022

Scientific Meetings and Exhibitions - CLS Participation Autumn 2022

The CLS team is looking forward to showcasing our new product generation towards urologists and radiologists through a variety of activities during the coming autumn...

Read more
9 June, 2022

CLS at Biostock Life Science Spring Summit

CEO Dan J. Mogren is presenting CLS at Biostock Life Science spring summit 2022. Watch the full presentation here.

Read more
19 May, 2022

SVT rapporterar om operationer i magnetkamera på Skånes universitetssjukhus

SVTs lokalnyheter sände i tisdags ett reportage från Skånes universitetssjukhus där patienter opereras inne i en magnetkamera. Så kommer det också gå till när Skånes universitetssjukhus inleder laserablationsbehandlingar av hjärntumörer - med CLS system.

Read more
17 May, 2022

Laserkirurgi i magnetkamera - för bättre precision och patientsäkerhet

CLS och Skånes Universitetssjukhus ser fram mot den kommande kliniska studie där CLS system för laserablation kommer utvärderas för behandling av patienter med tumörsjukdomen glioblastom.

Read more
11 May, 2022

CLS has entered an agreement with Quadia Diagnostic Imaging Center, Poland on a commercial evaluation of our TRANBERG® Thermal Therapy System

CLS has entered an agreement with Quadia Diagnostic Imaging Center in Piaseczno, Poland on a commercial evaluation of its second-generation TRANBERG® Thermal Therapy System with Thermoguide™ Workstation in MR-guided stereotactic focal laser ablation of localized prostate cancer.

Read more
21 April, 2022

CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

CLS Americas today announced the first patient has been safely treated in its recently announced 20-patient, Phase I clinical study.

Read more
20 April, 2022

CLS will participate with a booth and hands-on training during ECIO 2022, April 24-27 in Vienna, Austria

CLS is looking forward to participating in the annual European Conference on Interventional Oncology (ECIO) 2022, April 24-27 in Vienna, Austria. The meeting is the world’s most comprehensive platform for education and knowledge exchange within interventional oncology with over 1 450 international delegates attending.

Read more
5 April, 2022

CLS Americas Inc. and URN Announce Clinical Study “Targeted MRI/US Fusion Transperineal Laser Ablation of Low to Intermediate Risk Prostate Cancer”

Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used by Focalyx Technologies, developer of image-guided fusion target devices, to conduct a 20-patient, Phase I clinical study titled, “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

Read more
18 February, 2022

Radboud University Medical Center (Nijmegen, NL) has initiated a clinical trial using the CLS TRANBERG® products for patients with prostate cancer​

Radboud University Medical Center (Radboudumc) in Nijmegen in the Netherlands has obtained approval from its ethics committee for its Investigator Initiated Trial (IIT) to evaluate the safety and feasibility of magnetic resonance guided focused laser ablation (MRgFLA) as a focal therapy treatment for localized prostate cancer in low to intermediate risk patients, using the TRANBERG® Thermal Therapy System with Thermoguide™ Workstation.

Read more
16 February, 2022

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate laser ablation in glioblastoma patients​

CLS and Skåne University Hospital enter a clinical trial agreement to evaluate laser ablation in glioblastoma patients Clinical Laserthermia Systems AB (publ) (CLS), which develops advanced innovative products for high-precision image guided laser ablation, announces that it has entered into an agreement with Skåne University Hospital to sponsor a clinical trial evaluating the safety and feasibility of […]

Read more

Elementor Author

Robert Bergkvist
Developer
+46 735 01 07 14
support@dynamicdog.se

Elementor Document List

Summary of Safety and Performance, issued July 2024
Kallelse
Notice
Motiverat Yttrande Valberedningen_SE
Nomination Committee's Motivated Statement_EN
Fullmaktsformulär
Proxy Form
Wilson H, Dhawan S, Do T H, Jones S and Chen CThe Clearpoint Prism laser ablation system. Neurosurgery Practise 2024
H Singh, C R Osswald, A Rossman, V Knappe, L Schneider, L Floyd, and J D RolstonPreclinical assessment of a noncooled MR thermometry–based neurosurgical laser therapy system. J Neurosurg March , 2024
CLS Americas Announces 2nd Order of TRANBERG™ Focal Laser Ablation Accessories Placed by the National Institutes of Health Clinical Center, April 9, 2024
CLS Americas Announces ROSE Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation, March 28, 2024
Q&A CLS Omvänd aktiesplit Reverse Stock Split
Kallelse
Notice
Beslutsförslag
Bilaga 2 - Styrelsens redogörelse
Revisors yttrande
Fullmaktsformulär
Proxy form_EN
CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System, November 21, 2023
CLS Americas States KASRAEIAN Urology will use TRANBERG Laser to Treat Prostate Cancer Patients with Focal Laser Ablation, November 9, 2023
CLS Americas and HALO Diagnostics Initiate Prostate Cancer Clinical Study using TRANBERG Focal Laser Ablation System, November 7, 2023
CLS Americas Announces Kearney Urology Center will use its TRANBERG Laser to Provide Focal Laser Ablation Treatments to Prostate Cancer Patients, October 24, 2023
CLS Americas Debuts Mobile Service Program for Office-Based Focal Laser Ablation at Western Section AUA Meeting, October 3, 2023
CLS Americas Presents its TRANBERG™ System for Image-Guided Focal Laser Ablation at Focal Therapy Society 2023 Conference, September 7, 2023
CLS Americas and Focalyx Co-Marketing Agreement for Image-Guided Focal Laser Ablation of Prostate Tumors Using TRANBERG and Focalyx Fusion Systems, August 25, 2023
Kallelse
Notice
Fullständiga beslutsförslag inför årsstämma i CLS 2023
Fullmaktsformulär
Proxy Form
CLS Americas Announces the National Institutes of Health Clinical Center Placed its 1st Order of the TRANBERG™ Thermal Therapy System for its Research Study - MRI/Ultrasound Fusion-Guided FLA of Prostate Tissue and Prostate Cancer, June 1, 2023
Kallelse
Notice
Fullmaktsformulär
Proxy Form
Fullständiga beslutsförslag inför extra bolagsstämma
Complete proposals for resolutions for the Extraordinary General Meeting
CLS Americas Announces AVANT Concierge Urology has Treated its First Prostate Cancer Patients using the TRANBERG™ Thermal Therapy System, May 11, 2023
CLS Americas and Unio Health Partners Announce Clinical Study “Micro Ultra-Sound Guided Focal Laser Ablation of Low to Intermediate Risk Prostate Cancer”, April 25, 2023
CLS Americas Announces Agreement with AVANT Concierge Urology to Treat Prostate Cancer Patients with TRANBERG™ Thermal Therapy System, April 19, 2023
CLS Americas Announces Research Collaboration with the National Institutes of Health Clinical Center, April 13, 2023
CLS Americas and HALO Diagnostics Announce 25 Patient Study, February 8, 2023
CLS Americas and URN Announce Treatment of Final Patient in Clinical Study, “Targeted MRI/US Fusion Transperineal FLA, January 31, 2023
CLS Americas Exhibits TRANBERG Fusion-Guided FLA at WUSA, November 1, 2022
CLS Americas Presents Fusion-Guided FLA Solution at Unio Health Partner Summit, October 7, 2022
CLS Americas & Focalyx Exhibit at FOCAL Conference, September 23, 2022
CLS Exhibits Fusion-Guided FLA Solution at AUA 2022 Conference, May 12, 2022
CLS and URN Announce First Patient Treated in Clinical Study for Targeted FLA of Low-to-Intermediate Risk Prostate Cancer, April 20, 2022
CLS Americas & URN Announce New 20 Patient Clinical Study, Fusion-Guided FLA, March 29, 2022
CLS Americas Names Michael Magnani President, January 3, 2022
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors, October 25, 2021
CLS and University Hospital Magdeburg Begin Study of MRI US Fusion-Guided FLA of Prostate Cancer, July 7, 2021
CLS Americas Opens New Offices in Irvine, CA, January 14, 2021
CLS Receives New CPT Code by AMA for Fusion-Guided FLA of Prostate Cancer, November 4, 2020
Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S, Bottomley D, Eggener S, Ehdaie B, Emberton M, Hindley R, Leslie T, Miners A, McCartan N, Moore CM, Pinto P, Polascik TJ, Simmons L, van der Meulen J, Villers A, Willis S, Ahmed HU.Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting. Eur Urol. 2015 Apr;67(4):771-777.
Fujihara A, Ukimura O.Focal therapy of localized prostate cancer. Int J Urol. 2022 Nov;29(11):1254-1263.
Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, McCluskey S, Konukhova A, Hlasny E, van der Kwast TH, Incze PF, Zlotta AR, Hamilton RJ, Haider MA, Kucharczyk W, Perlis N.MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 2021 Mar;298(3):695-703.
Heard JR, Naser-Tavakolian A, Nazmifar M, Ahdoot M.Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. Prostate Cancer Prostatic Dis. 2022 Mar 4.
Hopstaken JS, Bomers JGR, Sedelaar MJP, Valerio M, Fütterer JJ, Rovers MM.An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol. 2022 Jan;81(1):5-33.
Kayano PP, Klotz L.Current evidence for focal therapy and partial gland ablation for organ-confined prostate cancer: systematic review of literature published in the last 2 years. Curr Opin Urol. 2021 Jan;31(1):49-57.
Lee T, Mendhiratta N, Sperling D, Lepor H.Focal laser ablation for localized prostate cancer: principles, clinical trials, and our initial experience. Rev Urol. 2014;16(2):55-66.
Walser EM, Sze TF, Ross JR, Karamanian AA, Woodrum DAMRI-Guided Prostate Interventions. AJR Am J Roentgenol. 2016 Oct;207(4):755-763. doi: 10.2214/AJR.16.16663.
Eric Walser, Anne Nance, Leslie Ynalvez, Shan Yong, Jacqueline S. Aoughsten, Eduardo J. Eyzaguirre, Stephen B. Williams, Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease, Journal of Vascular and Interventional Radiology
Patient story_Eng
Press Release CLS - URN 20th patient treated
Summary of Safety and Performance, issued Jan 2023
Appendix to Christmas Greeting 2022
CLS Brochure: Focal Therapy with MRI guided laser ablation
Kallelse
Förtydligande inför extra bolagsstämma
Fullständiga beslutsförslag inför stämma
Fullmaktsformulär
Villkor för teckningsoptioner TO 5 Terms for warrants of series TO 5
Subscription Form CLS WITHOUT RIGHTS ENG
Subscription Form CLS WITH RIGHTS ENG
CLS Cover Sheet ENG
Anmälningssedel CLS - utan rättigheter SE
Anmälningssedel CLS - med rättigheter SE
CLS Försättsblad SE
Teaser 2022 på svenska
Teaser 2022_ENG
Villkor för teckningsoptioner av serie TO 5 /Terms for warrants of series TO 5
Clinical Laserthermia Systems AB - Prospekt
Focal Therapy with fusion-guided laser ablation_brochure US
Fullständiga beslutsförslag inför Årsstämma i CLS 2022
Formulär för fullmakt CLS Årsstämma 2022
Kallelse till Årsstämma 2022
Proxy form CLS AGM 2021
Notification of attendance and form for advance voting CLS AGM 2021
Formulär för förfullmakt CLS årsstämma 2021
Formulär för förhandsröstning CLS årsstämma 2021
Valberedningens förslag CLS årsstämma 2021
Kallelse till Årsstämma 2021
Protokoll AGM 2021
Axelsson J, Pantaleone C, Åström S (2017)Initial Findings of Immunostimulating Interstitial Laser Thermotherapy of Solid Tumours. Journal for Clinical Studies 9(4): 28-31
Haraldsdóttir KH, Ingvar C, Stenram U, Tranberg KG.Long-term Follow-up After Interstitial Laser Thermotherapy of Breast Cancer. Anticancer Res. 2015 Nov; 35(11): 6147-52.
Huld-Haraldsdottir, KristinInterstitial laser thermotherapy (ILT) of breast cancer – Methodology and immunological response. Lund University Faculty of Medicine Doctoral Dissertation Series 2013: 93
Haraldsdottir KH, Ivarsson K, Jansner K, Stenram U, Tranberg K-G.Changes in immunocompetent cells after interstitial laser thermotherapy of breast cancer. Cancer Immunol Immunother 2011; 60 :847-56
Huld Haraldsdottir K, Ivarsson K, Götberg S, Ingvar C, Stenram U, Tranberg K-G.Interstitial laser thermotherapy (ILT) for breast cancer: initial experience. Eur J Surg Oncol 2008; 34: 739-745
Tranberg K-G.Laser tumor thermotherapy: Is there a clinically relevant effect on the immune system? Biophotonics and Immune Responses, Biomedical Optics, Proceedings of SPIE, 2006; 6087: 60870, B-1–B-12 (invited paper)
Tranberg K-G.Percutaneous ablation of liver tumours (invited review). Best Practice & Research Clin Gastroenterol 2004; 18:125-145
Tranberg K-G, Ivarsson K, Willner J, Håkansson L, Stenram U. Induction of a distant anti-tumour effect by interstitial laser thermotherapy (ILT) in a patient with malignant melanoma. 2nd International Conference on Tumor Microenvironment: Progression, Therapy and Prevention, Baden, Austria 2002, p 49
Tranberg K-G, Möller PH, Hannesson P, Stenram U.Interstitial laser treatment of malignant tumours: initial experience. Eur J Surg Oncol 1996; 22: 47-54
Tranberg K-G, Möller PH.Interstitial laser thermotherapy: preliminary experience in patients. SPIE 1995; PM 25: 468-476
Sturesson C, Ivarsson K, Stenram U, Andersson-Engels S, Tranberg K-G. Interstitial laser thermotherapy of a rat liver tumour: effect of hepatic inflow occlusion. Lasers Surg Med 2011; 43: 29-35
Ivarsson K, Myllymäki L, Jansner K, Stenram U, Tranberg K-G. Resistance to tumour challenge after tumour laser thermotherapy is associated with a cellular immune response. Br J Cancer 2005; 93: 435-440
Ivarsson K, Myllymäki L, Jansner K, Bruun A, Stenram U, Tranberg K-G.Heat shock protein 70 (HSP70) after laser thermotherapy of an adenocarcinoma transplanted into rat liver. Anticancer Res 2003; 23:3703-3712
Ivarsson K, Sturesson C, Stenram U, Tranberg K-G. Linomide augments the tumouricidal effect of interstitial laser thermotherapy in a rat liver tumour model. Anticancer Res 2003; 23:1257-1264
Tranberg K-G, Myllymäki L, Möller PH, Ivarsson K, Sjögren HO, Stenram U.Interstitial laser thermotherapy of a rat liver adenocarcinoma. J X-Ray Sci Technol 2002; 10: 177-185
Sturesson C, Ivarsson K, Andersson-Engels S, Tranberg K-G. Changes in local hepatic blood perfusion during interstitial laser-induced themotherapy of normal rat liver measured by interstitial laser Doppler flowmetry. Lasers Med Sci 1999; 14: 143-149
Olsrud J, Wirestam R, Persson BRR, Tranberg K-G.Simplified treatment planning for interstitial laser thermotherapy by disregarding light transport: a numerical study. Lasers Surg Med 1999; 25:304-314
Olsrud J, Wirestam R, Persson BRR, Tranberg K-G.Finite element analysis for simplified thermal dose planning in interstitial laser thermotherapy. In Thermal Therapy, Laser Welding and Tissue Interaction, Stephen G Bown, Guy P Delacrétaz, Guilhelm Godlewski, Gerhard Müller, Roberto Pini, Hans-Dieter Reidenbach, Rudolf W Steiner, Lars O Svaasand, Karl-Göran Tranberg, Editors, Proceedings of SPIE, 1998, vol. 3565: 24-29
Ivarsson K, Olsrud J, Sturesson C, Möller PH, Persson BRR, Tranberg K-G. A feedback interstitial diode laser (805 nm) thermotherapy system: ex vivo evaluation and mathematical modeling with one and four fibers. Lasers Surg Med 1998; 22:86-96
Möller PH, Ivarsson K, Stenram U, Radnell M, Tranberg K-GComparison between interstitial laser thermotherapy and excision of an adenocarcinoma transplanted into rat liver. Br J Cancer 1998; 77: 1884-1892
Olsrud J, Wirestam R, Brockstedt S, Nilsson AMK, Tranberg K-G, Holtås S, Ståhlberg F, Persson BRR. MRI thermometry in phantoms by use of the proton resonance frequency shift method: application to interstitial laser thermotherapy. Phys Med Biol 1998; 43:2597-2613
Möller PH, Hannesson P, Ivarsson K, Olsrud J, Stenram U, Tranberg K-G.Interstitial laser thermotherapy in pig liver: effect of inflow occlusion on extent of necrosis and ultrasound image. Hepato-Gastroenterology 1997; 44:1302-1311
Möller PH, Ivarsson K, Stenram U, Radnell M, Tranberg K-G.Interstitial laser thermotherapy of an adenocarcinoma transplanted into rat liver. Eur J Surg 1997; 163: 861-870
Möller PH, Lindberg L, Henriksson PH, Persson BRR, Tranberg K-G.Temperature control and light penetration in a feedback interstitial laser thermotherapy system. Int J Hyperthermia 1996; 12:49-63
Möller PH, Lindberg L, Tranberg K-G. Interstitial laser thermotherapy: comparison between bare fibre and sapphire probe. Lasers Med Sci 1995; 10:193-200
Tranberg K-G, Ivarsson K, Möller PH.Interstitial laser thermotherapy using feedback control and monitoring with electrical impedance tomography: review of studies in vitro and in vivo. SPIE 1995; PM 25: 354-365
Tranberg K-G, Möller PH, Lindberg L, Henriksson PH, Persson BRR.Energy delivery and monitoring in interstitial laser thermotherapy. Minimal Invasive Med 1994; 5:36-41
Möller PH, Tranberg K-G, Blad B, Henriksson PH, Lindberg L, Weber L, Persson BRR.EIT for measurement of temperature distribution in laser thermotherapy (laserthermia). In: Clinical and Physiological Applications of Electrical Impedance Tomography, ed. D Holder, 1993; 217-226
Henriksson PH, Persson BRR, Bladh B, Tranberg K-G, Möller P.Development of an EIT system for thermal mapping and process control. In: Tomographic Techniques for Process Design and Operation, eds. MS Beck, E Campogrande, M Morris, RA Williams, RC Waterfall. Computational Mechanics Publications, Southampton, 1993; 323-332

Elementor subscription

Subscribe to news

Select the type of news you want

Welcome to Clinical Laserthermia Systems.

Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!


Please choose your country or region

Global
US